Pillstats
Capsule

Celecoxib

Celecoxib

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01XX33
RxCUI (US)140587
US makers1 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.031$0.062$0.093$0.123Dec 2025Apr 2026Jul 2026
$0.082
Latest avg · Jul 22, 2026
-14%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

Only one quarter on record so far — the trend line fills in as more quarters load.

12
Rx · 2026 Q1
581
Units dispensed
1
Quarters · since 2026 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Actavis Pharma, Inc.unknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 15, 2025
    RESOLVEDShortage resolved: Celecoxib Capsule (Teva Pharmaceuticals USA, Inc.)

    Celecoxib Capsule — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction.

  • Aug 15, 2025
    SHORTAGEDrug shortage: Celecoxib Capsule (Teva Pharmaceuticals USA, Inc.)

    Celecoxib Capsule — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction.